Roche Gets Adjuvant ALK+ Lung Cancer To Itself With Alecensa Approval

 
• By Joseph Haas
  
FDA food and drug administration approval health pharmacy certification
Roche gets a third indication for NSCLC drug Alecensa
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from New Products

More from Scrip